ANDA 203028, held by Alicora. Metoprolol Succinate.
As of Nov 16, 2026, ANDA 203028 (Metoprolol Succinate), held by Alicora, was first approved by FDA on Mar 31, 2020, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 31, 2020 | Original application | Approved | None posted |
| Metoprolol SuccinateEQ 25MG TARTRATE · tablet, extended release;oral | Metoprolol Succinate | Rx |
| Metoprolol SuccinateEQ 50MG TARTRATE · tablet, extended release;oral | Metoprolol Succinate | Rx |
| Sep 26, 2023 | Supplement 6Labeling · Standard review | Approved | None posted |
| Sep 26, 2023 | Supplement 8Labeling · Standard review | Approved | None posted |
| Mar 31, 2020 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters